Advanced Biomedical Research

CASE REPORT
Year
: 2017  |  Volume : 6  |  Issue : 1  |  Page : 168-

Niemann–Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis


Farzan Kianersi, Seyed Ali Sonbolestan 
 Department of Ophthalmology, Eye Research Centre, Isfahan University of Medical Sciences, Isfahan, Iran

Correspondence Address:
Dr. Seyed Ali Sonbolestan
Feiz Hospital, Isfahan University of Medical Sciences, Isfahan
Iran

Abstract

In this study, we report a 26-year-old female case of Niemann–Pick disease type C in association with Fuchs heterochromic iridocyclitis who was admitted with the complaint of ocular pain and redness following trauma. She had mild inflammatory signs and also vertical ocular motility limitations.



How to cite this article:
Kianersi F, Sonbolestan SA. Niemann–Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis.Adv Biomed Res 2017;6:168-168


How to cite this URL:
Kianersi F, Sonbolestan SA. Niemann–Pick Disease Type C Associated with Fuchs Heterochromic Iridocyclitis. Adv Biomed Res [serial online] 2017 [cited 2018 Sep 25 ];6:168-168
Available from: http://www.advbiores.net/text.asp?2017/6/1/168/221859


Full Text

 Introduction



Niemann–Pick disease type C (NP-C) is a rare neurodegenerative disease.[1] Abnormal saccadic eye movements (SEMs) are frequently the earliest neurological sign appreciated in NP-C. In most patients, the initial deficit is in the vertical plane; however, finally, the horizontal plane may be affected too.[2],[3]

Fuchs heterochromic iridocyclitis (FHI) is a chronic nongranulomatous disease. Its exact etiology is unknown; however, some associations with many other diseases such as toxoplasmosis, rubella vaccination, herpes simplex virus, cytomegalovirus, retinitis pigmentosa, Usher's syndrome, and previous trauma were explained previously.[4]

In this study, we report one case of NP-C in association with FHI.

 Case Report



A 26-year-old female with the complaint of ocular pain and redness (in the right eye) following trauma was admitted to ophthalmology emergency room. According to her mother's history, the patient had a medical history of developmental delay, auditory impairment, the history of generalized tonic–clonic seizures, and also ataxic gait since the toddler age and she had some school difficulties since childhood. Furthermore, according to her medical documents, the history of gastroesophageal reflux disease was noted but she had no history of pulmonary or splenic abnormalities.

Her ocular examination finding included of: best-corrected visual acuities were 4/10 and 8/10 (OD and OS, respectively), and in slit-lamp examination of the right eye, a subconjunctival hemorrhage, trace (0.5–1+) anterior chamber reaction, a mild posterior subcapsular cataract, diffuse fine keratic precipitates, and mild (1+) vitreous cells were identified. Mild iris atrophy was seen in the right eye. The slit-lamp examination of the left eye was normal. Intraocular pressure and fundus examination revealed no abnormal findings [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5].{Figure 1}{Figure 2}{Figure 3}{Figure 4}{Figure 5}

In ocular motility testing, limitation in vertical gazes (both up and down gazes) was found. According to the patient and her mother's history, this problem had existed from childhood, and over the years, it progressed, and she has had difficulties in reading [Figure 6].{Figure 6}

The paraclinic findings included of complete blood count, serum electrolytes, lipid profile, serum copper and ceruloplasmin, erythrocyte sedimentation rate, C-reactive protein, serum transaminases, urea, creatinine, and blood urea nitrogen were in the normal range. Furthermore, serum antinuclear and antiphospholipid antibodies were negative. Purified protein derivative skin test, rapid plasma reagin test, and Venereal Disease Research Laboratory test were also negative. Chest X-ray was normal.

A magnetic resonance imaging (MRI) was done before in which cerebellar atrophy was reported [Figure 7].{Figure 7}

Furthermore, it was cleared that her cousin had similar neurologic and ocular motility findings; however, no other similar findings were reported in her family. The patient's parents did not have any relationship.

 Discussion



NP-C disease has several neurologic, cognitive, and ocular manifestations and is linked with the autosomal recessive inheritance of mutations of the genes, NPC1 and NPC2.[5]

About the ophthalmic abnormalities, these patients do not have retinal pigment abnormalities or cherry-red spot. However, abnormal SEM is often present as the initial neurological abnormality in NP-C. In the majority of patients, the primary SEM deficit is in the vertical plane, which results in difficulties in downward, upward, and eventually both gazes. After that, the horizontal gazes are disturbed too. Subsequently, these changes cause complete supranuclear gaze palsy and so the limitation of patients in reading and following the targets. According to the previous studies, vertical supranuclear gaze palsy is known as the prominent sign of NP-C which is usually diagnosed in the late infantile period and after that.[2],[3]

Neuropsychiatric manifestations are commonly diagnosed from the late infantile period and after that. Young patients (especially 6–15 years) sometimes have difficulties at school and/or behavioral problems as reported in our patient. In the majority of patients, the progressive cognitive decline is common. Some of the other neurologic problems included of abnormal muscle tone or posture, incoordination, limited working ability, and seizures or cataplexy are known.

Laboratory biochemistry profiles including blood biochemistry, plasma lipids, and unconjugated bilirubin are commonly normal in NP-C patients, but can be changed in those with hypersplenism or cholestatic liver disease. Low HDL-C is communal. A mild thrombocytopenia can occasionally be detected in patients with splenomegaly. Plasma transaminases are mostly normal; however, aspartate aminotransferase can be elevated but generally returns to normal.[1]

Plasma chitotriosidase seems to be a marker for severity of the disorder; however, its usefulness is not proven and also it is neither sensitive nor specific. Anyway, laboratory tests for NP-C are not forthright. Many different biochemical and molecular approaches are suggested for diagnosis, but none of them is exact. In the meantime, the diagnosis is suggested on the basis of physical examination and signs of the disease and ruling out of other differential diagnoses. The exact diagnostic evaluations done in patients assumed to have NP-C can depend on the regional availability of resources and expertise.[1]

MRI could reveal some findings such as cerebral atrophy and/or marked atrophy of the superior or anterior cerebellar vermis. Some of the patients may show some small degrees of cerebral atrophy or thinning of the corpus callosum. Furthermore, some of them may have white matter signal hyperintensity lesions in T2-weighted MRIs.[6]

Until lately, there was no disease-modifying treatment for NP-C. Helpful therapies are variably effective for the lessening of clinical appearances of this disease. Palliative pharmacotherapy is used for dystonia, seizures, sleep disorders, gastrointestinal symptoms, and rarely, lung involvement.[1] In the meantime, our patient was only treated by anticonvulsant therapy and sometimes proton pump inhibitors such as Omeprazole.

The incidence of FHI is about 0.2% and consists of about 6% of all uveitis patients.[7] In this case, the patient had been followed for about 3 years, and all the immunologic and infectious evaluations were negative during this period. Hence, according to ocular signs and symptoms, the diagnosis of FHI was suggested. The patient was not treated for her FHI disease as it seemed to be controlled; however, reassurance was done about her traumatic findings.

 Conclusion



Here, a case of NP-C disease who suffered also from FHI is presented, and hence, it could be added to the long list of FHI associations.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.

References

1NP-C Guidelines Working Group, Wraith JE, Baumgartner MR, Bembi B, Covanis A, Levade T, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab 2009;98:152-65.
2Solomon D, Winkelman AC, Zee DS, Gray L, Büttner-Ennever J. Niemann-Pick type C disease in two affected sisters: Ocular motor recordings and brain-stem neuropathology. Ann N Y Acad Sci 2005;1039:436-45.
3Lengyel D, Weissert M, Schmid L, Gottlob I. Eye movement abnormalities as a sign for the diagnosis in Niemann-Pick disease type C. Klin Monbl Augenheilkd 1999;214:50-2.
4Babu K, Adiga M, Govekar SR, Kumar BR, Murthy KR. Associations of Fuchs heterochromic iridocyclitis in a South Indian patient population. J Ophthalmic Inflamm Infect 2013;3:14.
5Millat G, Baïlo N, Molinero S, Rodriguez C, Chikh K, Vanier MT. Niemann-Pick C disease: Use of denaturing high performance liquid chromatography for the detection of NPC1 and NPC2 genetic variations and impact on management of patients and families. Mol Genet Metab 2005;86:220-32.
6Sévin M, Lesca G, Baumann N, Millat G, Lyon-Caen O, Vanier MT, et al. The adult form of Niemann-Pick disease type C. Brain 2007;130(Pt 1):120-33.
7Lichtinger A, Chowers I, Amer R. Usher syndrome associated with Fuchs' heterochromic uveitis. Graefes Arch Clin Exp Ophthalmol 2010;248:1481-5.